$47.730
-0.158 (-0.33%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
LBRX-Prognose durch Analyse ähnlicher Charts
Alphio's LBRX stock price prediction model matches the current LB Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $48.38 (+1.37%). The 1-week path is $46.80 (-1.95%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich LB Pharmaceuticals Inc-Aktien kaufen?
LB Pharmaceuticals Inc is a good buy right now due to its current price of $47.73, which is below the analyst price targets of $60 and $69, suggesting significant upside potential. The stock has shown a remarkable year-to-date change of +133.51% and a one-year change of +218.20%, indicating strong momentum. However, the main risk is the negative earnings per share (EPS) of -1.71 reported in the last earnings, which reflects ongoing financial challenges that investors should monitor closely.
LBRX schloss am Friday bei $47.73, nachdem der Kurs -0.33% fallen
LB Pharmaceuticals Inc (LBRX) last closed at $47.73, losing -0.33%. These facts feed the 1-day and 1-week LBRX price prediction above.
Prognose-Treiber
Die Prognose-Treiber von LB Pharmaceuticals Inc (LBRX) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf LBRX am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für LBRX
Historically the probability of a positive August return for LBRX is 100.00%. February offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.